Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen Torkko

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 28, 2007
Effect of tamoxifen on endometrial histology, hormone receptors, and cervical cytology: a prospective study with follow-upKimberly K Leslie, Sarah A Walter, Kathleen Torkko, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 8, 2011
Differential expression of transferrin receptor (TfR) in a spectrum of normal to malignant breast tissues: implications for in situ and invasive carcinomaMeenakshi Singh, Kimberly Mugler, Dulan W Hailoo, et al.
Pilot and Feasibility Studies|September 6, 2022
Guided imagery for treatment (GIFT): protocol of a pilot trial of guided imagery versus treatment as usual to address radiotherapy-related distress in head and neck cancerElissa Kolva, Sana D Karam, Alaina L Carr, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 14, 2017
Fascin Is Associated With Aggressive Behavior and Poor Outcome in Uterine CarcinosarcomaAbby M Richmond, Erin A Blake, Kathleen Torkko, et al.
Human Pathology|July 17, 2004
Biomorphometric analysis of human prostatic carcinoma by using three-dimensional computer modelsPriya N Werahera, Gary J Miller, Kathleen Torkko, et al.
The Journal of Urology|February 1, 2015
Active Surveillance is an Appropriate Management Strategy for a Proportion of Men Diagnosed with Prostate Cancer by Prostate Specific Antigen TestingStephen Overholser, Matthew Nielsen, Kathleen Torkko, et al.
Molecular Cancer Research : MCR|August 26, 2018
A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient PlasmaLisa I Greene, Tullia C Bruno, Jessica L Christenson, et al.
Molecular Cancer Therapeutics|May 5, 2017
Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast CancerMichael A Gordon, Nicholas C D'Amato, Haihua Gu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 28, 2020
Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention TrialKathleen Torkko, Cathee Till, Catherine M Tangen, et al.
Molecular Cancer Research : MCR|April 13, 2021
<i>MAP3K7</i> Loss Drives Enhanced Androgen Signaling and Independently Confers Risk of Recurrence in Prostate Cancer with Joint Loss of <i>CHD1</i>Lauren K Jillson, Leah C Rider, Lindsey U Rodrigues, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 28, 2007
Effect of tamoxifen on endometrial histology, hormone receptors, and cervical cytology: a prospective study with follow-upKimberly K Leslie, Sarah A Walter, Kathleen Torkko, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 8, 2011
Differential expression of transferrin receptor (TfR) in a spectrum of normal to malignant breast tissues: implications for in situ and invasive carcinomaMeenakshi Singh, Kimberly Mugler, Dulan W Hailoo, et al.
Pilot and Feasibility Studies|September 6, 2022
Guided imagery for treatment (GIFT): protocol of a pilot trial of guided imagery versus treatment as usual to address radiotherapy-related distress in head and neck cancerElissa Kolva, Sana D Karam, Alaina L Carr, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 14, 2017
Fascin Is Associated With Aggressive Behavior and Poor Outcome in Uterine CarcinosarcomaAbby M Richmond, Erin A Blake, Kathleen Torkko, et al.
Human Pathology|July 17, 2004
Biomorphometric analysis of human prostatic carcinoma by using three-dimensional computer modelsPriya N Werahera, Gary J Miller, Kathleen Torkko, et al.
The Journal of Urology|February 1, 2015
Active Surveillance is an Appropriate Management Strategy for a Proportion of Men Diagnosed with Prostate Cancer by Prostate Specific Antigen TestingStephen Overholser, Matthew Nielsen, Kathleen Torkko, et al.
Molecular Cancer Research : MCR|August 26, 2018
A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient PlasmaLisa I Greene, Tullia C Bruno, Jessica L Christenson, et al.
Molecular Cancer Therapeutics|May 5, 2017
Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast CancerMichael A Gordon, Nicholas C D'Amato, Haihua Gu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 28, 2020
Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention TrialKathleen Torkko, Cathee Till, Catherine M Tangen, et al.
Molecular Cancer Research : MCR|April 13, 2021
<i>MAP3K7</i> Loss Drives Enhanced Androgen Signaling and Independently Confers Risk of Recurrence in Prostate Cancer with Joint Loss of <i>CHD1</i>Lauren K Jillson, Leah C Rider, Lindsey U Rodrigues, et al.
Pageof 2